Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
246 GBX | +0.41% | -0.42% | +8.59% |
04-22 | EEnergy Group Lands GBP5 Million Contract for Photovoltaic Systems | MT |
04-22 | EEnergy jumps on GBP5.2 million contract with Spire Healthcare | AN |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company has a low valuation given the cash flows generated by its activity.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company sustains low margins.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.59% | 1.24B | B- | ||
-18.46% | 16.57B | B+ | ||
+4.50% | 12.43B | B | ||
+4.98% | 11.69B | B+ | ||
+4.59% | 10.24B | B+ | ||
-3.10% | 7.59B | A- | ||
+20.21% | 7.15B | D | ||
+6.45% | 6.8B | B- | ||
+50.68% | 4.65B | - | ||
-5.12% | 4.22B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SPI Stock
- Ratings Spire Healthcare Group plc